FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
The WHO urged nations to come forward with information regarding the origins of the COVID-19 virus and not play "geopolitical football" as it.
The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south.
Antidepressant drug consumption is on the rise in Europe, and Iceland tops the list, followed by Portugal and the UK, according to the.
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to.
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
A large study provides clues on how long immunity lasts against Covid reinfection and does vaccination help in reducing its severity
Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.